We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.49B
AUM Growth
+$308M
Cap. Flow
-$9.33M
Cap. Flow %
-0.27%
Top 10 Hldgs %
56.89%
Holding
645
New
145
Increased
110
Reduced
156
Closed
135

Sector Composition

Rank Sector Weight
1 Energy 34.28%
2 Technology 15.43%
3 Healthcare 14.7%
4 Industrials 8%
5 Materials 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCYC
151
Bicycle Therapeutics
BCYC
$278M
$2.12M 0.06%
84,980
+11,379
+15% +$242K
APCA
152
DELISTED
AP Acquisition Corp
APCA
$2.12M 0.06%
187,581
MCD icon
153
McDonald's
MCD
$196B
$2.11M 0.06%
+7,500
New +$2.18M
IP icon
154
International Paper
IP
$21.5B
$2.1M 0.06%
53,760
-69,540
-56% -$2.52M
PK icon
155
Park Hotels & Resorts
PK
$2.89B
$2.09M 0.06%
+119,275
New +$1.93M
BZAI
156
Blaize Holdings
BZAI
$138M
$2.07M 0.06%
187,581
SLAM
157
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$2.03M 0.06%
182,628
LEGT.U
158
DELISTED
Legato Merger Corp III Units
LEGT.U
$2.03M 0.06%
+200,000
New +$2.02M
ON icon
159
ON Semiconductor
ON
$18.6B
$2.02M 0.06%
27,500
-40,500
-60% -$3.1M
ARCH
160
DELISTED
Arch Resources, Inc.
ARCH
$2.01M 0.06%
+12,500
New +$2.14M
RARE icon
161
Ultragenyx Pharmaceutical
RARE
$2.54B
$1.99M 0.06%
42,606
-14,350
-25% -$677K
TWLO icon
162
Twilio
TWLO
$29.3B
$1.99M 0.06%
+32,500
New +$2.14M
NTES icon
163
NetEase
NTES
$83.5B
$1.97M 0.06%
19,058
+268
+1% +$27.4K
ESTA icon
164
Establishment Labs
ESTA
$2.33B
$1.96M 0.06%
38,445
-10,000
-21% -$401K
VSAC
165
DELISTED
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
$1.96M 0.06%
175,381
MRSN
166
DELISTED
Mersana Therapeutics
MRSN
$1.95M 0.06%
17,372
-4,854
-22% -$483K
NBIX icon
167
Neurocrine Biosciences
NBIX
$16.2B
$1.93M 0.06%
14,000
-5,796
-29% -$792K
WOLF icon
168
Wolfspeed
WOLF
$1.43B
$1.92M 0.05%
+65,000
New +$1.96M
NLY icon
169
Annaly Capital Management
NLY
$17.1B
$1.9M 0.05%
96,500
-36,993
-28% -$713K
KIDS icon
170
OrthoPediatrics
KIDS
$586M
$1.89M 0.05%
64,814
+24,500
+61% +$685K
IMCR icon
171
Immunocore
IMCR
$1.75B
$1.88M 0.05%
28,924
+1,283
+5% +$88K
ANAB icon
172
AnaptysBio
ANAB
$1.62B
$1.87M 0.05%
83,025
-4,099
-5% -$97.1K
KNSA icon
173
Kiniksa Pharmaceuticals
KNSA
$5.97B
$1.86M 0.05%
94,495
-6,227
-6% -$122K
XFOR icon
174
X4 Pharmaceuticals
XFOR
$393M
$1.86M 0.05%
44,517
-13,584
-23% -$378K
IONS icon
175
Ionis Pharmaceuticals
IONS
$9.06B
$1.84M 0.05%
42,412
+13,788
+48% +$657K

Similar funds

UBS O'Connor's Q1 2024 Portfolio in Review

As of Q1 2024, UBS O'Connor held 645 positions worth $3.49B, up 9.7% from $3.18B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

UBS O'Connor's Q1 2024 filing shows 145 new, 110 increased, 156 reduced and 135 closed positions. Its largest new stake was Juniper Networks: 4,428,704 shares worth $164M. The largest sale was Splunk Inc, an estimated $561M.

By sector, the portfolio is most concentrated in Energy at 34% of assets, up from 30% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q1 2024 buy was Juniper Networks: 4,428,704 shares worth $164M.
  • UBS O'Connor added most to Axonics, Inc. Common Stock in Q1 2024, an estimated $128M increase.
  • UBS O'Connor's biggest Q1 2024 reduction was Pioneer Natural Resource Co., cutting an estimated $34M.
  • UBS O'Connor fully exited Splunk Inc in Q1 2024, selling an estimated $561M.
  • UBS O'Connor's ten largest holdings make up 57% of its $3.49B portfolio in Q1 2024.
  • UBS O'Connor opened 145 new positions and closed 135 in Q1 2024.
  • UBS O'Connor's portfolio value rose 9.7% quarter-over-quarter to $3.49B.

Based on UBS O'Connor's 13F filing for Q1 2024, filed 15 May 2024.